Furthermore, a significantly higher NK cell signature score in mild COVID-19 (Figure 5J) further supported the hypothesis of impaired NK-like differentiation in severe SARS-CoV-2 infection, which appeared to be present already at the early stage of CD16+ CD8+ TEMRA-1 cells. The gene discussed is CD8A; the disease is COVID-19.